v3.26.1
Unaudited Condensed Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Total
Ordinary Shares
Additional paid in capital
Accumulated deficit
Accumulated other comprehensive income
Treasury Stock
Beginning balance (in shares) at Dec. 31, 2024   1,082,614,740        
Beginning balance at Dec. 31, 2024 $ 840,898 $ 7 $ 3,264,295 $ (2,453,083) $ 50,515 $ (20,836)
Beginning balance (in shares) at Dec. 31, 2024           (4,912,200)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of ordinary shares upon vesting of restricted shares (in shares)   137,540        
Issuance of ordinary shares upon vesting of restricted shares 0 $ 0 0      
Exercise of share options (in shares)   6,324,120        
Exercise of share options 3,733 $ 0 3,733      
Issuance cost of the follow-on public offering (28)   (28)      
Share-based compensation 15,800   15,800      
Net loss (48,438)     (48,438)    
Foreign currency translation (1,212)       (1,212)  
Ending balance (in shares) at Mar. 31, 2025   1,089,076,400        
Ending balance at Mar. 31, 2025 810,753 $ 7 3,283,800 (2,501,521) 49,303 $ (20,836)
Ending balance (in shares) at Mar. 31, 2025           (4,912,200)
Beginning balance (in shares) at Dec. 31, 2024   1,082,614,740        
Beginning balance at Dec. 31, 2024 840,898 $ 7 3,264,295 (2,453,083) 50,515 $ (20,836)
Beginning balance (in shares) at Dec. 31, 2024           (4,912,200)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (89,165)          
Foreign currency translation (4,167)          
Ending balance (in shares) at Jun. 30, 2025   1,104,032,910        
Ending balance at Jun. 30, 2025 791,735 $ 7 3,308,491 (2,542,248) 46,348 $ (20,863)
Ending balance (in shares) at Jun. 30, 2025           (4,920,020)
Beginning balance (in shares) at Mar. 31, 2025   1,089,076,400        
Beginning balance at Mar. 31, 2025 810,753 $ 7 3,283,800 (2,501,521) 49,303 $ (20,836)
Beginning balance (in shares) at Mar. 31, 2025           (4,912,200)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of ordinary shares upon vesting of restricted shares (in shares)   9,698,120        
Issuance of ordinary shares upon vesting of restricted shares 0 $ 0 0      
Exercise of share options (in shares)   5,258,390        
Exercise of share options 7,718 $ 0 7,718      
Receipt of shares netted to satisfy tax withholding obligations related to share-based compensation (in shares)           (7,820)
Receipt of shares netted to satisfy tax withholding obligations related to share-based compensation (27)         $ (27)
Share-based compensation 16,973   16,973      
Net loss (40,727)     (40,727)    
Foreign currency translation (2,955)       (2,955)  
Ending balance (in shares) at Jun. 30, 2025   1,104,032,910        
Ending balance at Jun. 30, 2025 $ 791,735 $ 7 3,308,491 (2,542,248) 46,348 $ (20,863)
Ending balance (in shares) at Jun. 30, 2025           (4,920,020)
Beginning balance (in shares) at Dec. 31, 2025 1,106,389,340 1,113,822,550        
Beginning balance at Dec. 31, 2025 $ 715,500 $ 7 3,343,469 (2,628,620) 29,697 $ (29,053)
Beginning balance (in shares) at Dec. 31, 2025 (7,433,210)         (7,433,210)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of ordinary shares upon vesting of restricted shares (in shares)   371,630        
Issuance of ordinary shares upon vesting of restricted shares $ 0 $ 0 0      
Exercise of share options (in shares)   4,641,010        
Exercise of share options 833 $ 0 833      
Receipt of shares netted to satisfy tax withholding obligations related to share-based compensation (in shares)           (1,169,360)
Receipt of shares netted to satisfy tax withholding obligations related to share-based compensation (2,268)         $ (2,268)
Share-based compensation 13,524   13,524      
Net loss (51,016)     (51,016)    
Foreign currency translation (14,592)       (14,592)  
Ending balance (in shares) at Mar. 31, 2026   1,118,835,190        
Ending balance at Mar. 31, 2026 $ 661,981 $ 7 3,357,826 (2,679,636) 15,105 $ (31,321)
Ending balance (in shares) at Mar. 31, 2026           (8,602,570)
Beginning balance (in shares) at Dec. 31, 2025 1,106,389,340 1,113,822,550        
Beginning balance at Dec. 31, 2025 $ 715,500 $ 7 3,343,469 (2,628,620) 29,697 $ (29,053)
Beginning balance (in shares) at Dec. 31, 2025 (7,433,210)         (7,433,210)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss $ (101,841)          
Foreign currency translation $ (29,483)          
Ending balance (in shares) at Jun. 30, 2026 1,122,445,390 1,132,222,310        
Ending balance at Jun. 30, 2026 $ 607,037 $ 7 3,370,798 (2,730,461) 214 $ (33,521)
Ending balance (in shares) at Jun. 30, 2026 (9,776,920)         (9,776,920)
Beginning balance (in shares) at Mar. 31, 2026   1,118,835,190        
Beginning balance at Mar. 31, 2026 $ 661,981 $ 7 3,357,826 (2,679,636) 15,105 $ (31,321)
Beginning balance (in shares) at Mar. 31, 2026           (8,602,570)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of ordinary shares upon vesting of restricted shares (in shares)   8,585,230        
Issuance of ordinary shares upon vesting of restricted shares 0 $ 0 0      
Exercise of share options (in shares)   4,801,890        
Exercise of share options 1,031 $ 0 1,031      
Receipt of shares netted to satisfy tax withholding obligations related to share-based compensation (in shares)           (1,174,350)
Receipt of shares netted to satisfy tax withholding obligations related to share-based compensation (2,200)         $ (2,200)
Share-based compensation 11,941   11,941      
Net loss (50,825)     (50,825)    
Foreign currency translation $ (14,891)       (14,891)  
Ending balance (in shares) at Jun. 30, 2026 1,122,445,390 1,132,222,310        
Ending balance at Jun. 30, 2026 $ 607,037 $ 7 $ 3,370,798 $ (2,730,461) $ 214 $ (33,521)
Ending balance (in shares) at Jun. 30, 2026 (9,776,920)         (9,776,920)